Flagship explainer
How Niagen Bioscience, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $129M | 100% |
| |
| Cost of revenue | $46.2M | 36% |
|
| $83.2M | 64% |
| |
| $16.3M | 13% |
| |
| Income before tax | $18.2M | 14% |
|
| Income tax | $810000 | 1% |
|
| $17.4M | 13% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001386570-26-000013